193 related articles for article (PubMed ID: 10082496)
21. Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.
Jackman HL; Massad MG; Sekosan M; Tan F; Brovkovych V; Marcic BM; Erdös EG
Hypertension; 2002 May; 39(5):976-81. PubMed ID: 12019279
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
23. ACE activity is modulated by kinin B2 receptor.
Sabatini RA; Guimarães PB; Fernandes L; Reis FC; Bersanetti PA; Mori MA; Navarro A; Hilzendeger AM; Santos EL; Andrade MC; Chagas JR; Pesquero JL; Casarini DE; Bader M; Carmona AK; Pesquero JB
Hypertension; 2008 Mar; 51(3):689-95. PubMed ID: 18212275
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
[TBL] [Abstract][Full Text] [Related]
25. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
26. Ca2+ release and Ca2+ influx in Chinese hamster ovary cells expressing the cloned mouse B2 bradykinin receptor: tyrosine kinase inhibitor-sensitive and- insensitive processes.
Taketo M; Yokoyama S; Kimura Y; Higashida H
Biochim Biophys Acta; 1997 Jan; 1355(1):89-98. PubMed ID: 9030205
[TBL] [Abstract][Full Text] [Related]
27. Bradykinin potentiation by ACE inhibitors: a matter of metabolism.
Tom B; Dendorfer A; de Vries R; Saxena PR; Jan Danser AH
Br J Pharmacol; 2002 Sep; 137(2):276-84. PubMed ID: 12208785
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor?
Hecker M; Bara AT; Busse R
Immunopharmacology; 1996 Jun; 33(1-3):93-4. PubMed ID: 8856122
[TBL] [Abstract][Full Text] [Related]
29. Kinins, receptors, kininases and inhibitors--where did they lead us?
Erdös EG; Marcic BM
Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
[TBL] [Abstract][Full Text] [Related]
30. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
[TBL] [Abstract][Full Text] [Related]
31. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.
Chen Z; Deddish PA; Minshall RD; Becker RP; Erdös EG; Tan F
FASEB J; 2006 Nov; 20(13):2261-70. PubMed ID: 17077303
[TBL] [Abstract][Full Text] [Related]
32. Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release.
Hecquet C; Biyashev D; Tan F; Erdös EG
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H948-58. PubMed ID: 16183725
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium.
Rump LC; Berlit T; Schwertfeger E; Beyersdorf F; Schollmeyer P; Bohmann C
J Hypertens; 1997 Nov; 15(11):1263-70. PubMed ID: 9383175
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme regulates bradykinin receptor gene expression.
Ignjacev-Lazich I; Kintsurashvili E; Johns C; Vitseva O; Duka A; Shenouda S; Gavras I; Gavras H
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H1814-20. PubMed ID: 16219810
[TBL] [Abstract][Full Text] [Related]
35. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
36. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Tom B; Dendorfer A; Danser AH
Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
[TBL] [Abstract][Full Text] [Related]
37. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
38. Activation of bradykinin B1 receptor by ACE inhibitors.
Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
Int Immunopharmacol; 2002 Dec; 2(13-14):1787-93. PubMed ID: 12489793
[TBL] [Abstract][Full Text] [Related]
39. Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors.
Boehm S; Huck S
Br J Pharmacol; 1997 Oct; 122(3):455-62. PubMed ID: 9351501
[TBL] [Abstract][Full Text] [Related]
40. Regulation of inducible bradykinin B1 receptor gene expression through absence of internalization and resensitization.
Zhou X; Prado GN; Taylor L; Yang X; Polgar P
J Cell Biochem; 2000 Jun; 78(3):351-62. PubMed ID: 10861834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
